Fused protein for enzyme immunoassay system
AssigneeCalifornia Biotechnology Inc.
InventorsDale B. Schenk, Sharon K. Spratt
Life of this patent
Estimating the term…
Abstract
A fused protein for use in an enzyme immunoassay system. The protein comprises an enzymatically active .beta.-galactosidase fused, at its C terminus, to an immunologically active peptide. The protein is produced using a plasmid containing a complete .beta.-galactosidase gene fused, at its 3' end, with an oligonucleotide coding for the peptide. The fused protein is designed for use in a solid-phase enzyme immunoassay system, based on immunospecific binding of the fused protein to a solid support, or in a homogeneous enzyme immunoassay system, based on enzyme inhibition resulting from immunospecific binding of an antibody to the protein.
Claims10
A fused protein for use in a homogeneous enzyme immunoassay, comprising an enzymatically active .beta.-galactosidase fused, at its C terminus, to an immunologically active peptide of human surfactant apoprotein (HSA), and having the property that binding of anti-HSA antibody to said immunologically active peptide inhibits the .beta.-galactosidase activity of said protein.
A plasmid for use in producing in a bacterial host, a fused protein composed of enzymatically active beta-galactosidase fused at its C terminus to an immunologically active peptide of HSA, and having the property that binding of anti-HSA antibody to said protein inhibits .beta.-galactosidase activity of said protein, comprising:
- (a) an origin or replication which permits plasmid replication in the host,
- (b) lactose-controlling elements, and
- (c) a complete-sequence B-galactosidase gene which is under control of said lactose-controlling elements and which terminates at a unique EcoRI site.
A method of producing a fused protein for use in a homogeneous enzyme immunoassay system designed for determination of a protein or peptide analyte, comprising:
- (a) selecting a peptide which is immunologically reactive with an antibody which is cross-reactive with an antigenic region of the analyte;
- (b) providing a nucleotide sequence coding for such peptide;
- (c) constructing a plasmid having a .beta.-galactosidase gene which (1) encodes for enzymatically active .beta.-galactosidase in a suitable host, and (2) terminates at its 3'-end at a selected restriction endonuclease site;
- (d) inserting the peptide-coding sequence into the plasmid at such restriction site;
- and
- (e) selecting a plasmid transfected host which produces a fused protein which (1) has .beta.-galactosidase activity, (2) is immunologically reactive with an antibody specific against such peptide, and (3) shows increasing inhibition of .beta.-galactosidase activity in response to increasing levels of said antibody added to the fused protein.
A homogenous enzyme immunoassay system for determination of a peptide or protein analyte, comprising:
- (a) an anti-analyte antibody effective to bind immunospecifically to said analyte;
- (b) a fused protein composed of an enzymatically active .beta.-galactosidase enzyme fused, at its C terminus, to an immunologically active peptide which is effective to bind said antibody, in proportion to the amount of analyte present in an assay mixture containing the fused protein, antibody, and analyte, to reduce the specific .beta.-galactosidase activity of the fused protein.
Dependencies are inferred from the claim text.